International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers

Author(s): Allen Loyd V Jr, Williams LaVonn A

Issue: Jul/Aug 2012 - Volume 16, Number 4
View All Articles in Issue

Page(s): 294-298

Note: Electronic version includes supplemental material.

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 1

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 2

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 3

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 4

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Page 5

Download in electronic PDF format for $75

Abstract: Drug shortages, which are at an all-time high, and discontinued drugs have patients, physicians, and pharmacists scrambling for answers to the problem of unavailable drugs. Needless to say these problems have created unnecessary discomfort for patients and have put patients in life and death situations. This article discusses some of the possible reasons for the problems and how they affect patients and those healthcare providers who are dedicated to the medical treatment of patients.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, LaVonn A. Williams, drug shortages, discontinued drugs, patient care, U.S. Food and Drug Administration, FDA

Related Categories: LEGAL, DISCONTINUED FORMULATIONS, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 294-298
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 350-351
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
PreScription: Discontinued Drugs and Drug Shortages Allen Loyd V Jr	Mar/Apr 2011 Pg. 92
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
The Role of Compounding Pharmacists During Drug Shortages Ofei Kelvin	Jul/Aug 2022 Pg. 298-301
PreScription: Drug Shortages and Discontinued Drugs Allen Loyd V Jr	Jul/Aug 2012 Pg. 268
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Allowing Compounding Pharmacies to Address Drug Shortages Broughel James	Mar/Apr 2022 Pg. 100-109
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna	Nov/Dec 2012 Pg. 456-460
Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients Moore Renee	Sep/Oct 2012 Pg. 394-395
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Brunner Scott	Jul/Aug 2020 Pg. 296-297
PreScription: Compounding for Drug Shortages Allen Loyd V Jr	May/Jun 2013 Pg. 180
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Allen Loyd V Jr, Ashworth Lisa D	Jan/Feb 2005 Pg. 44-46
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A	Jan/Feb 2019 Pg. 32-33
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Kupiec Tom, Kemp Jesse	Jul/Aug 2007 Pg. 326-327
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Allen Loyd V Jr	Jul/Aug 2007 Pg. 350-351
Return to Top